Vivia Biotech has developed a proprietary ex vivo assay to measure B-cell proliferation under native immune conditions. This assay allows for the precise evaluation of how therapeutic agents modulate B-cell expansion, a key process in many autoimmune diseases. Having a reliable method to assess B-cell proliferative activity is essential for understanding drug mechanisms and identifying compounds with the potential to modulate pathogenic immune responses.